TSH Biopharm Corp. Ltd.(TW:8432)
NT$61.90+0.40 (+0.65%)
TW:8432
TSH Biopharm Corp. Ltd. financials statements
NT$61.90
At close:+0.40 (+0.65%)
TSH Biopharm Corp. Ltd. (8432) Financial Statements
TSH Biopharm Corp. Ltd. Financial Overview
TSH Biopharm Corp. Ltd.'s market cap is currently NT$2.36B. The company's EPS TTM is NT$4.35; its P/E ratio is 11.30; and it has a dividend yield of 4.22%. TSH Biopharm Corp. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.34B | NT$ 1.12B | NT$ 810.92M | NT$ 741.07M | NT$ 413.48M |
| Gross Profit | NT$ 657.13M | NT$ 582.76M | NT$ 399.90M | NT$ 389.87M | NT$ 247.36M |
| Operating Income | NT$ 218.37M | NT$ 170.62M | NT$ 63.63M | NT$ 84.98M | NT$ 61.53M |
| EBITDA | NT$ 245.11M | NT$ 202.84M | NT$ 99.35M | NT$ 103.47M | NT$ 71.31M |
| Net Income | NT$ 139.26M | NT$ 113.09M | NT$ 61.99M | NT$ 61.89M | NT$ 47.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 932.28M | NT$ 897.36M | NT$ 772.12M | NT$ 815.77M | NT$ 733.40M |
| Total Assets | NT$ 1.95B | NT$ 1.84B | NT$ 1.40B | NT$ 1.44B | NT$ 1.17B |
| Total Debt | NT$ 26.44M | NT$ 36.96M | NT$ 7.84M | NT$ 63.86M | NT$ 5.01M |
| Net Debt | NT$ -438.10M | NT$ -551.38M | NT$ -568.74M | NT$ -425.05M | NT$ -376.88M |
| Total Liabilities | NT$ 233.79M | NT$ 219.22M | NT$ 133.63M | NT$ 222.46M | NT$ 85.80M |
| Stockholders' Equity | NT$ 1.44B | NT$ 1.39B | NT$ 1.11B | NT$ 1.14B | NT$ 1.08B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 150.29M | NT$ 181.03M | NT$ 28.32M | NT$ 15.62M | NT$ 68.33M |
| Operating Cash Flow | NT$ 154.81M | NT$ 183.77M | NT$ 33.87M | NT$ 34.35M | NT$ 68.71M |
| Investing Cash Flow | NT$ -171.37M | NT$ -110.38M | NT$ 161.02M | NT$ 33.40M | NT$ -10.06M |
| Financing Cash Flow | NT$ -107.24M | NT$ -61.69M | NT$ -107.18M | NT$ -89.40M | NT$ -73.46M |
Currency in TWD
